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Purified Plasma Membranes Inhibit
Polypeptide Growth Factor-induced DNA Synthesis
in Subconfluent 3T3 Cells
The growth in culture of untransformed fibroblasts such as
murine 3T3 cells, is dependent on a variety of factors in
serum as well as on cell density. Numerous theories have been
proposed to explain the observations that such cells achieve
maximal densities when cultured under a defined set of con-
ditions (1). The most frequently cited ofthese theories explain
the regulation of maximal cell density through constraints
that have their origin in direct cell-to-cell contact (2, 3) or
limitations in the concentration and/or accessibility of cells
to essential growth factors in the serum (4, 5). Whittenberger
and Glaser (6) reported a provocative series of experiments in
which the addition of 3T3 cell surface membranes to subcon-
fluent 3T3 cells inhibited the ability of these cells to enter the
S phase (DNA synthesis) of the cell cycle, suggesting that
membrane-membrane interactions play an important role in
growth regulation. Recently, a protein has been extracted and
partially purified from these membranes that demonstrates
the same growth regulatory effects when added to 3T3 cells
(7).
Since serum contains a variety of polypeptide factors that
are essential for the propagation and maintenance of mam-
malian cellsin culture, we investigated whether plasma mem-
branes alter the proliferative response of 3T3 cells to purified
growth factors under serum-deprived conditions. Epidermal
growth factor (EGF)' (8), fibroblast growth factor (FGF) (9),
'Abbreviations used in thispaper: DME, Dulbecco's modified Eagle's
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ABSTRACT
￿
Plasma membranes derived from NR-6 cells, a varient line of Swiss mouse 3T3 cells that
does not have cell surface receptors for epidermal growth factor (EGF), inhibited EGF-induced
stimulation of DNA synthesis by 50% in serum-starved, subconfluent 3T3 cells. Membranes derived
from SV3T3 cells were much less effective in inhibiting EGF-induced DNA synthesis. This inhibition
on DNA synthesis by NR-6 membranes was not a direct effect of membranes on EGF, nor could it
be overcome by high concentrations of EGF . NR-6 membranes were most effective when added 3
h before EGF addition and had little effect when added 2 h or more after EGF. NR-6 membranes
also reduced the stimulation of DNA synthesis induced by platelet-derived growth factor or fibroblast
growth factor in serum-starved 3T3 cells. These findings indicate that membrane-membrane inter-
actions between nontransformed cells may diminish their ability to proliferate in response to serum
polypeptide growth factors.
and platelet-derived growth factor (PDGF) (10) are all potent
mitogens for 3T3 cells. In this report, we document that
plasma membranes when added to subconfluent 3T3 cells
limit the ability of these cells to proliferate in response to
these mitogenic factors.
MATERIALS AND METHODS
Cell Culture:
￿
Swiss mouse 3T3 cells (clone 42 from G. Todaro, Na-
tional Institutes of Health), a SV40-transformed variant ofthese cells (SV3T3),
and NR-6 cells were grown in Dulbecco's modified Eagle's medium (DME)
plus 10% fetal calfserum as previously described (11). NR-6 is a variant cell
line obtained from clone 42 3T3 cells that has no detectable EGF-binding
activity (12).
Serum-starved 3T3 cells were prepared in the following manner. Swiss 3T3
cells were plated in a 2-cm' Costar wells at a density of -2 x 10' cells/cm' in
DME plus 5% fetal calf serum (FCS). 24 h later the medium was changed to
DME containing 0.5% FCS, and the cells were incubated for an additional 24
h. Cultures that were 30-40% confluent at the time of membrane addition
were used in these experiments.
Plasma Membrane Preparation:
￿
NR-6 orSV3T3cellswere grown
to confluency on 100-mm Falcon dishes (Falcon Labware, Oxnard, CA) in
DME plus 10% fetal calfserum. Plasma membranes were prepared from these
cells essentially as described by Whittenberger and Glaser (6). Membrane
concentrations are expressed in units of phosphodiesterase (PDE) activity (1
unit of phosphodiesterase activity hydrolyzes 10 nmol of substrate per hour)
medium; EGF, epidermal growth factor; FCS, fetal calf serum; FGF,
fibroblast growth factor; PDE, phosphodiesterase; PDGF, platelet-
derived growth factor; SV3T3, a SV40-transformed variant of Swiss
mouse 3T3 cells.
1129(13). Whittenberger and Glaser (6) have found that the specific activities of
phosphodiesterase in 3T3 and SV3T3 membranes are similar, thus indicating
that similar amounts ofmembrane are being added.
PolypeptideHormone Preparations:
￿
EGF was purified from the
submaxillary glands of adult male mice by the method of Savage and Cohen
(14). FGF, derived from bovine pituitary glands was a gift from D. Gospoda-
rowicz, University of California, San Francisco. An extract containing PDGF
was prepared from outdated human platelets as described by Antonaides and
Scher (15). Purified PDGF was obtained from R. Ross, University ofWashing-
ton.
Measurements of DNA Synthesis:
￿
['H]Thymidine incorporation
into acid-precipitable material was performed on 3T3 cells grown in 2-cm2
Costar wells. Cells were washed once with DME plus 0.5% FCS, and 1 yCi
(0.55 1AM) ['H]Thymidine (New England Nuclear, Boston, MA) was added in
1 ml ofDME plus 0.5% undialyzed FCS. After a 1-h incubation at 37°C, cells
were washed twice with cold Hanks' salt solution and incubated with 2 ml of
5% trichloroacetic acid at 4°C for 30 min. Cells were then washed twice with
cold 5% trichloroacetic, twice with methanol and solubilized with 0.5 ml of0.5
N NaOH. This solution was transferred to scintillation vials together with 70
ral of 12 N HCl and 10 ml ofscintillation fluid (Amersham, Arlington Heights,
IL), and radioactivity was counted in a liquid scintillation counter. .
For labeled nuclei experiments, duplicate 2-cm' Linbro wells of 3T3 cells
were treated with 2 PDE units ofSV3T3 or NR-6 membranes and incubated
18 h at 37°C in DME plus 0.5% FCS, or in DME plus 0.5% FCS and 25 ng/
ml EGF. Autoradiography of ['H]thymidine labeled nuclei was performed on
these cells by treating them with 1 gCi ['H]thymidine (0.55 'UM) in 1 ml of
DME plus 0.25% undialized FCS. After a 1-h incubation at 37°C, cells were
washed twice-with cold Hanks' salt solution, fixed 45 min in 1 ml of a 3.7%
formaldehyde solution, and rinsed twice with distilled water. The cells were
layered with NTB2 nuclear track emulsion (Kodak) and incubated for 5 d at
0°C. The emulsion was developed with D-19 developer (Kodak), fixed in 30%
sodium thiosulfate, and the cells stained with 1 % toluidine blue (Fisher Scien-
tific Co., Pittsburgh, PA). Percent of labeled nuclei was quantitated by light
microscopy.
RESULTS
Whittenberger and Glaser (6) demonstrated that cell surface
membranes derived from confluent Swiss mouse 3T3 cells
inhibit DNA synthesis by 50% or greater in subconfluent 3T3
cells grown in the presence of 10% FCS. We have obtained
identical results when plasma membranes from NR-6, a cell
line derived from 3T3 which does not display EGF receptors
yet still demonstrates density-dependent growth, were added
to subconfluent cultures of 3T3 cells in 10% FCS (data not
shown). We subsequently investigated the effects of plasma
membranes derived from NR-6 cells on the stimulation of
DNA synthesis induced by EGF in serum-starved 3T3 cells.
NR-6 membranes were ideal for this study because they do
not bind EGF and hence cannot deplete it from the medium.
Fig. 1 describes an experimentin which plasma membranes
derived from NR-6 or SV3T3 were tested for their ability to
inhibit EGF-induced stimulation of DNA synthesis. Subcon-
fluent 3T3 cells were arrested in the G phaseof the cell cycle
by serum deprivation. EGF was then added to membrane-
treated and untreated cells, and DNA synthesis was deter-
mined by measuring the incorporation of[3H]thymidine. The
addition of NR-6 membranes to the cells decreased the EGF-
induced stimulation of DNA synthesis by >50%. Further-
more, this effect could not be overcome by high concentra-
tions of EGF (50 ng/ml) suggesting that NR-6 membranes
and EGF are not in direct competition for a common site.
Maximal inhibition was observed at a membrane concentra-
tion of 1 PDE unit (data not shown).
In contrast to the observations with NR-6 membranes,
plasma membranes derived from SV3T3 cells only produced
a small decrease in EGF-induced mitogenesis (Fig. 1). Higher
concentrations of SV3T3 membranes did not produce a
greater inhibition. This observation presumably reflects the
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FIGURE 1
￿
Inhibition of EGF-induced DNA synthesis in 3T3 cells
by plasma membranes. Serum-starved 3T3 cells were prepared in
2-cm2 Costar wells as described in Materials and Methods, and
incubated for 3 h at 37°C in 0.5 ml of DME plus 0.5% FCS containing
no membranes (9) or 2 PDE units of purified membranes from NR-
6 (O) or SV3T3 cells (x). Media and membranes not adhering to the
cells or dish were then aspirated, and the cells were washed three
times with DME plus 0.5% FCS. EGF was added at the concentra-
tions indicated in 1 ml of the same medium, and ['H]thymidine
incorporation into DNA was determined 24 h later. All points are
the mean values from three independent determinations. The bars
indicate the range of experimental variation.
inability of this viral transformed cell line to cease growth
even at very high cell densities (16). Similarly, Whittenberger
and Glaser (6) reported that SV3T3 membranes failed to
substantially inhibit serum-induced DNA synthesis in 3T3
cells.
To confirm that measurement of [3H]thymidine incorpo-
ration is a valid determination ofDNA synthesis, autoradiog-
raphyof nuclei labeled with [3H]thymidine was performed. A
24-h incubation with EGF (25 ng/ml) increased the percent-
age of cells with labeled nuclei from 37% to 52% . However,
in cells treated with NR-6 surface membranes (2 PDE units
for 3 h), EGF only slightly increased the percentage oflabeled
nuclei from 34% to 37%. SV3T3 membranes (2 PDE units),
on the other hand, did not significantly affect the stimulation
by EGF (34% to 49%). Thus, inhibition of [3H]thymidine
incorporation by NR-6 membranes is due to an inhibition of
DNA synthesis and is not the result of altered membrane
transport of thymidine.
Since NR-6 cells cannot bind EGF, it is unlikely that NR-
6 membranes inhibit EGF-induced DNA synthesis by remov-
ing EGF from the medium or depleting its concentration at
the cell surface. Table I additionally shows that NR-6 mem-
branes do not inhibit mitogenesis by inactivating or degrading
EGF. In this experiment, NR-6 membranes were incubated
with medium containing EGF, and were then removed by
centrifugation. No reduction in the ability of this medium to
stimulate DNA synthesis was observed as a consequence of
previous membrane exposure, indicating that membranes
exert their actions on the cells rather than on EGF.
The inhibitory actions of NR-6 membranes on EGF-in-
duced DNA synthesis were maximal when membranes wereTABLE I
Retention of Biological Activity of EGFafter Incubation with
NR-6 Membranes
Samples of EGF (1 ng/ml) were exposed to four different treatments for 3 h
at 37°C: None, a control experiment in which EGF was incubated in DME/
0.5% FCS. NR-6 membranes, EGFwas incubated in 3 ml of DME/0.5% FCS
containing 5 PDE units of NR-6 membranes. 3T3 cells, EGF in DME/0.5%
FCS was incubated with subconfluent 3T3 cells. 3T3 cells plus membranes,
NR-6 membranes (2 PDE units/well) were incubated with serum-starved,
subconfluent 3T3 cells for 3 h, excess membranes washed away and EGF
added in DME/0.5% FCS. After these treatments, EGFsamples were centri-
fuged at 50,000 gfor 20 min in a SW50.1 rotor (Beckman Instruments, Inc.,
Palo AID, CA) at 4°C to pellet any membranes were present. Supernatant
fluids were removed and added to confluent, serum-starved 3T3 cells.
Stimulation of [3H]thymidine incorporation was measured 20 h later. Values
are expressed as the percent stimulation of [3H]thymidine incorporation of
EGF-treated as compared with untreated cells.
TABLE II
Effect of Time of Membrane Addition on the Inhibition of EGF-
induced DNA Synthesis
At time -3 h, serum-starved 3T3 cells were washed twice, and 0.5 ml of
DME plus 0.5% FCSwas added. EGF (5 ng/ml) was added at time 0h to all
samples, and NR-6 membranes (2 PDE units per well) were added before or
after EGF at the indicated times. ['H]Thymidine incorporation was deter-
mined 24 hlater. Values are expressed as the percent stimulation ofthymidine
incorporation of EGF-treated as compared with untreated cells. Values are
the mean and experimental variation of triplicate determinations .
incubated with 3T3 cells before EGF addition (Table II). NR-
6 membranes were less effective when added 2 h or more
after EGF addition. The results of this experiment suggest
that once cells become committed to enter S phase by EGF,
membranes are incapable of inhibiting DNA synthesis. Such
observations are also consistent with a study by Whittenberger
et al. (17) which showed that plasma membranes arrest 3T3
cells in Go of the cell cycle. These results also imply that the
effects of membranes are specific and not the result of toxic
actions upon cells. Further supporting the contention that
this effect is not due to membrane-induced toxicity, Whitten-
berger and Glaser (6) have shown that membrane-treated 3T3
cells have the same replating efficiency as control cells.
Serum contains a complex mixture of polypeptide growth-
promoting hormones. It was therefore important to determine
if NR-6 plasma membranes inhibit DNA synthesis induced
by growth factors other than EGF. FGF and PDGF are
polypeptide hormones which are potent mitogens for 3T3
cells (9, 10). Fig. 2 shows that NR-6 membranes reduced the
stimulation of DNA synthesis induced by an extract contain-
ing PDGF by 50% and inhibited the stimulation mediated by
FGF almost completely. We have also obtained similar results
DISCUSSION
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FIGURE 2
￿
Effect of NR-6 plasma membranes on thestimulation of
DNA synthesis induced by an extract containing PDGF (A) or FGF
(B). Experimental conditions are those described for Fig. 1 . FGF or
an extract containing PDGF were added at various concentrations
in 1 ml of DME plus 0.5% FCS, and [3H]thymidine incorporation
into DNA was measured 24 h later during a 1-h pulse labeling
period. All points are the mean values of duplicate determinations,
and the bars indicate the range of experimental variation.
using purified PDGF (data not shown). These results indicate
that plasma membranes act to inhibit an event that is com-
mon to the action of various growth-promoting hormones.
As mammalian cells grow in culture, some signal may be
generated to impart information on cell density. Such events
could lead to a cessation of growth. It has been speculated
that membrane-membrane interactions between cells might
be the primary event leading to quiescence. In support ofsuch
a notion, both the present studies and those by Whittenberger
and Glaser (6) have shown that plasma membranes affect the
growth of subconfluent 3T3 cells in a way that mimics the
density-dependent growth inhibition observed when 3T3 cells
approach confluency. Furthermore, Whittenberger et al. (7)
have partially purified a protein from detergent solubilized
membranes that acts in a fashion similar to that of whole
membranes. Natraj and Datta (18, 19) have described a
growth-inhibiting factor that is released from confluent
BALB/c 3T3 cells by treatment with urea.
Since serum can be replaced by appropriate combinations
of polypeptide growth hormones in order to support the
growth of mammalian cells in culture (20), it appears as
though polypeptide hormones provide the main stimuli for
the proliferation of these cells. Our results demonstrate that
plasma membranes alterthe mitogenic response of 3T3 cells
to three important growth hormones, EGF, FGF, and PDGF.
A specific membrane interaction is implicated, since SV3T3
cell-surface membranes are incapable of significantly reducing
RAPID COMMUNICATIONS
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Time of membrane addition
Stimulation of [3H]-
thymidine incorporation
(% of control)
h
-3 120.6 ± 15.0
+0.5 162 .0 ± 32 .8
+2 264.5 ± 32 .0
+16 302.5 ± 44.4
+20 295.8 ± 13.1
Control (no membranes) 303.1 ± 6.1
Components preincubated with EGF
Stimulation of [3H]-
thymidine incorporation
(% of control)
None 218.3 ± 13.3
NR-6 membranes 210.9 ± 7.2
3T3 cells 236.2 ± 15.4
3T3 cells + NR-6 membranes 234.1 ± 5.4EGF-induced mitogenesis. Such results indicate that plasma
membrane inhibition ofDNA synthesis of 3T3 cellsgrown in
10% serum observed both by us and by Whittenberger and
Glaser (6) may be the consequence of an altered cellular
response to the many polypeptide growth factors present in
serum. We propose that such mechanisms may play an im-
portant role in governing the density-dependent growth of
nontransformed cells in culture. However, such a model does
not necessarily exclude the importance of nutrient uptake (5,
21) and the release of inhibitory molecules (22) in growth
regulation.
The mechanism by which plasma membranes alter the
mitogenic actions of EGF, FGF, and PDGF is still unknown.
Our results suggest that membranes act to inhibit some event
that is common to the mitogenic pathways of a number of
polypeptide hormones. We have also shown that this mecha-
nism of inhibition does not involve depletion or inactivation
of at least one mitogen, EGF, in the medium. Furthermore,
Lieberman et al. (23) have reported that 3T3 cell membranes
do not alterthe binding capacity of 1251-EGF to subconfluent
3T3 cells. It has also been demonstrated that the number of
binding sites for EGF even increases as glial cells reach
confluency (24). Thus it is likely that the mechanism of
membrane-induced growth inhibition involves a step distal to
the initial interaction of the mitogen with its receptor. While
the biochemical events ofthe pathway of mitogenesis remain
to be elucidated, it has recently been demonstrated that both
EGF (25) and PDGF (26) are capable of activating tyrosine-
specific protein kinases that may be involved in initiating cell
growth. A modification of protein kinase activity as the result
of membrane-membrane interaction may be one means of
achieving growth regulation.
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